Promising new treatments for multiple sclerosis

(Medical Xpress)—New treatments for multiple sclerosis (MS) using common anti-psychotic agents have been discovered by Victoria University of Wellington researchers.

The study led by Dr Anne La Flamme, an associate professor in the School of Biological Sciences and head of the MS research programme at the Malaghan Institute of Medical Research, based at Victoria, shows the potential of clozapine and to effectively treat MS.

MS, a neurological disease which affects one in every 1,400 New Zealanders, is caused by immune cells invading the brain and causing inflammation. It leads to impaired vision and coordination and, eventually, paralysis, explains Dr La Flamme.

"While disease-modifying drugs are currently available, they are often effective in only a subpopulation of MS patients and all of these treatments target the disease through traditional immune pathways," she says.

"What makes our findings so important is that clozapine and risperidone target a very different set of pathways from all other MS drugs, and thus have the potential to treat those MS populations for which no effective therapies currently exist."

Published this week by international scientific journal PLOS ONE, the study demonstrates that risperidone and clozapine can reduce MS significantly by reducing the inflammation in the brain that causes this disease.

Additionally, this research indicates that the way and risperidone improve disease outcomes in MS is different from how these agents work to treat .

"By utilising existing therapies, this work may more quickly support improved outcomes for people with MS," says Dr La Flamme.

More information: The PLOS ONE article can be viewed online here: www.plosone.org/article/info%3… journal.pone.0104430

add to favorites email to friend print save as pdf

Related Stories

New knowledge about treating multiple sclerosis

Feb 03, 2014

(Medical Xpress)—A study carried out at Victoria, and recently published online in the international scientific journal PLOS ONE, holds promise for patients suffering from secondary progressive MS, an advanced form of the ...

HIV infection linked to lower multiple sclerosis risk

Aug 04, 2014

HIV infection is linked to a significantly lower risk of developing multiple sclerosis (MS), indicates observational research published online in the Journal of Neurology Neurosurgery & Psychiatry.

Scientists track origins of multiple sclerosis

Aug 07, 2014

The autoimmune response that is involved in multiple sclerosis (MS) was once thought to be confined to the brain. Yale researchers, however, have uncovered evidence that this damaging response may begin in ...

Recommended for you

What happens in our brain when we unlock a door?

11 minutes ago

People who are unable to button up their jacket or who find it difficult to insert a key in lock suffer from a condition known as apraxia. This means that their motor skills have been impaired – as a result ...

Sport can help multiple sclerosis patients

3 hours ago

A study developed at the Miguel Hernández University of Elche (Spain) has preliminarily concluded that people with multiple sclerosis may reduce perceived fatigue and increase mobility through a series of ...

Obama's BRAIN initiative gets more than $300 million

8 hours ago

President Barack Obama's initiative to study the brain and improve treatment of conditions like Alzheimer's and autism was given a boost Tuesday with the announcement of more than $300 million in funds.

User comments